Mo, Y., Kang, M., Xue, F., Xu, S., & Shi, J. (2023). Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiology and Oncology, 57(3), 405–410. Retrieved from https://radioloncol.com/index.php/ro/article/view/4122